Pointe Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.42M | Sell |
1,183
-1
| -0.1% | -$1.02K | 0.63% | 36 |
|
|
2026
Q1 | $1.09M | Sell |
1,184
-31
| -3% | -$31.4K | 0.54% | 43 |
|
|
2025
Q4 | $1.31M | Hold |
1,215
| – | – | 0.65% | 35 |
|
|
2025
Q3 | $927K | Hold |
1,215
| – | – | 0.45% | 50 |
|
|
2025
Q2 | $947K | Buy |
1,215
+19
| +2% | +$14.8K | 0.49% | 48 |
|
|
2025
Q1 | $988K | Hold |
1,196
| – | – | 0.58% | 44 |
|
|
2024
Q4 | $923K | Sell |
1,196
-21
| -2% | -$17.4K | 0.53% | 48 |
|
|
2024
Q3 | $1.08M | Sell |
1,217
-16
| -1% | -$14.4K | 0.63% | 35 |
|
|
2024
Q2 | $1.12M | Sell |
1,233
-70
| -5% | -$56K | 0.69% | 32 |
|
|
2024
Q1 | $1.01M | Sell |
1,303
-55
| -4% | -$39.1K | 0.62% | 37 |
|
|
2023
Q4 | $792K | Sell |
1,358
-65
| -5% | -$37.9K | 0.55% | 46 |
|
|
2023
Q3 | $764K | Sell |
1,423
-30
| -2% | -$15.5K | 0.56% | 45 |
|
|
2023
Q2 | $681K | Hold |
1,453
| – | – | 0.51% | 51 |
|
|
2023
Q1 | $499K | Sell |
1,453
-426
| -23% | -$144K | 0.36% | 67 |
|
|
2022
Q4 | $687K | Sell |
1,879
-125
| -6% | -$44.3K | 0.53% | 47 |
|
|
2022
Q3 | $648K | Hold |
2,004
| – | – | 0.52% | 50 |
|
|
2022
Q2 | $650K | Sell |
2,004
-100
| -5% | -$30K | 0.48% | 52 |
|
|
2022
Q1 | $602K | Hold |
2,104
| – | – | 0.38% | 67 |
|
|
2021
Q4 | $581K | Sell |
2,104
-104
| -5% | -$26.4K | 0.35% | 72 |
|
|
2021
Q3 | $510K | Hold |
2,208
| – | – | 0.35% | 79 |
|
|
2021
Q2 | $507K | Hold |
2,208
| – | – | 0.36% | 81 |
|
|
2021
Q1 | $412K | Buy |
2,208
+51
| +2% | +$9.98K | 0.29% | 89 |
|
|
2020
Q4 | $364K | Sell |
2,157
-482
| -18% | -$72K | 0.31% | 91 |
|
|
2020
Q3 | $391K | Hold |
2,639
| – | – | 0.34% | 83 |
|
|
2020
Q2 | $433K | Sell |
2,639
-79
| -3% | -$12.1K | 0.39% | 75 |
|
|
2020
Q1 | $377K | Hold |
2,718
| – | – | 0.37% | 69 |
|
|
2019
Q4 | $357K | Hold |
2,718
| – | – | 0.3% | 96 |
|
|
2019
Q3 | $304K | Sell |
2,718
-1,666
| -38% | -$185K | 0.26% | 107 |
|
|
2019
Q2 | $486K | Buy |
4,384
+11
| +0.3% | +$1.29K | 0.4% | 69 |
|
|
2019
Q1 | $567K | Buy |
4,373
+61
| +1% | +$7.42K | 0.48% | 61 |
|
|
2018
Q4 | $499K | Sell |
4,312
-1,245
| -22% | -$139K | 0.49% | 59 |
|
|
2018
Q3 | $596K | Buy |
5,557
+336
| +6% | +$33.6K | 0.47% | 61 |
|
|
2018
Q2 | $446K | Sell |
5,221
-555
| -10% | -$45.6K | 0.38% | 74 |
|
|
2018
Q1 | $447K | Buy |
5,776
+55
| +1% | +$4.43K | 0.39% | 77 |
|
|
2017
Q4 | $483K | Sell |
5,721
-195
| -3% | -$16.6K | 0.39% | 78 |
|
|
2017
Q3 | $506K | Buy |
5,916
+54
| +0.9% | +$4.43K | 0.37% | 82 |
|
|
2017
Q2 | $482K | Sell |
5,862
-151
| -3% | -$12.3K | 0.35% | 86 |
|
|
2017
Q1 | $506K | Buy |
+6,013
| New | +$482K | 0.39% | 79 |
|
|
2016
Q4 | – | Sell |
-6,225
| Closed | -$500K | – | 203 |
|
|
2016
Q3 | $500K | Sell |
6,225
-141
| -2% | -$11.3K | 0.36% | 86 |
|
|
2016
Q2 | $501K | Buy |
6,366
+2,500
| +65% | +$188K | 0.36% | 82 |
|
|
2016
Q1 | $278K | Buy |
3,866
+578
| +18% | +$43.7K | 0.22% | 120 |
|
|
2015
Q4 | $277K | Buy |
+3,288
| New | +$273K | 0.2% | 125 |
|
Other funds holding LLY
Pointe Capital Management's LLY Position: Q2 2026 in Review
Pointe Capital Management reduced its Eli Lilly (LLY) stake by 0.08% in Q2 2026, selling an estimated $1.02K and leaving 1,183 shares worth $1.42M. The position accounts for 0.63% of the portfolio, ranked #36.
Pointe Capital Management first reported a position in LLY in Q4 2015 and has held it in 42 quarters since. 4,628 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Pointe Capital Management held 1,183 shares of Eli Lilly worth $1.42M as of Q2 2026.
- Pointe Capital Management sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
- Eli Lilly made up 0.63% of Pointe Capital Management's portfolio in Q2 2026, its #36 holding.
- Pointe Capital Management first reported a position in Eli Lilly in Q4 2015 and has held it in 42 quarters since.
- 4,628 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Pointe Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.